心律失常：分子机制与治疗策略
Cardiac Arrhythmia: Molecular Mechanisms and Therapeutic Strategies.
作者信息
Okamoto Yosuke, Tsumoto Kunichika
机构信息
Department of Cell Physiology, Akita University Graduate School of Medicine, 1-1-1, Hondo, Akita 010-8543, Japan.
Department of Physiology II, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan.
出版信息
Int J Mol Sci. 2024 Dec 10;25(24):13253. doi: 10.3390/ijms252413253.
Abstract
Arrhythmias are divided into supraventricular and ventricular, depending on where they originate [...].
摘要
心律失常根据其起源部位分为室上性和室性[……]。
相似文献
1
Cardiac Arrhythmia: Molecular Mechanisms and Therapeutic Strategies.心律失常：分子机制与治疗策略
Int J Mol Sci. 2024 Dec 10;25(24):13253. doi: 10.3390/ijms252413253.
2
Role of the Purkinje system in heritable arrhythmias.浦肯野系统在遗传性心律失常中的作用。
Heart Rhythm. 2019 Jul;16(7):1121-1126. doi: 10.1016/j.hrthm.2019.01.034. Epub 2019 Feb 2.
3
[Can genetic analysis of repolarization lead to new strategies in the management of arrhythmia?].复极化的基因分析能否带来心律失常管理的新策略？
Cardiologia. 1998 Jun;43(6):589-96.
4
[Progress in cardiac electrophysiology and arrhythmias].[心脏电生理学与心律失常的进展]
Rev Esp Cardiol (Engl Ed). 2012 Jan;65 Suppl 1:73-81. doi: 10.1016/j.recesp.2011.10.034.
5
German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management.德国心脏病学会细胞电生理学工作组最新论文：分子机制对临床心律失常管理的影响。
Clin Res Cardiol. 2019 Jun;108(6):577-599. doi: 10.1007/s00392-018-1377-1. Epub 2018 Oct 10.
6
A genetic framework for improving arrhythmia therapy.改善心律失常治疗的遗传框架。
Nature. 2008 Feb 21;451(7181):929-36. doi: 10.1038/nature06799.
7
Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study.皮下和经静脉 ICD 心律失常检测算法的心律失常鉴别性能的头对头比较：START 研究。
J Cardiovasc Electrophysiol. 2012 Apr;23(4):359-66. doi: 10.1111/j.1540-8167.2011.02199.x. Epub 2011 Oct 28.
8
New approaches to antiarrhythmic therapy, part II: emerging therapeutic applications of the cell biology of cardiac arrhythmias.抗心律失常治疗的新方法，第二部分：心律失常细胞生物学的新兴治疗应用
Circulation. 2001 Dec 11;104(24):2990-4. doi: 10.1161/hc4901.099493.
9
Recognition and management of cardiac arrhythmias.心律失常的识别与处理
Curr Probl Cardiol. 1995 Feb;20(2):53-117.
10
Update on arrhythmias and cardiac pacing 2013.《2013年心律失常与心脏起搏最新进展》
Rev Esp Cardiol (Engl Ed). 2014 Apr;67(4):294-304. doi: 10.1016/j.rec.2013.12.012. Epub 2014 Mar 12.
本文引用的文献
1
Atrial Fibrillation and Underlying Structural and Electrophysiological Heterogeneity.心房颤动及潜在的结构和电生理异质性。
Int J Mol Sci. 2024 Sep 23;25(18):10193. doi: 10.3390/ijms251810193.
2
Facilitation of hERG Activation by Its Blocker: A Mechanism to Reduce Drug-Induced Proarrhythmic Risk.其阻滞剂促进 hERG 激活：降低药物致心律失常风险的一种机制。
Int J Mol Sci. 2023 Nov 13;24(22):16261. doi: 10.3390/ijms242216261.
3
Ionic Mechanisms of Propagated Repolarization in a One-Dimensional Strand of Human Ventricular Myocyte Model.离子机制在一维人心室肌细胞模型中传播复极化。
Int J Mol Sci. 2023 Oct 19;24(20):15378. doi: 10.3390/ijms242015378.
4
The W101C Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes.W101C 突变通过组成型激活的 GIRK 通道在 hiPSC 衍生的心肌细胞中诱导更缓慢的起搏。
Int J Mol Sci. 2023 Oct 18;24(20):15290. doi: 10.3390/ijms242015290.
5
Bioinformatic Identification of Potential RNA Alterations on the Atrial Fibrillation Remodeling from Human Pulmonary Veins.从人肺静脉中鉴定心房颤动重构的潜在 RNA 改变的生物信息学方法。
Int J Mol Sci. 2023 Jun 22;24(13):10501. doi: 10.3390/ijms241310501.
6
miR-181b targets semaphorin 3A to mediate TGF-β-induced endothelial-mesenchymal transition related to atrial fibrillation.miR-181b 通过靶向 SEMA3A 介导 TGF-β诱导的与心房颤动相关的内皮-间质转化。
J Clin Invest. 2022 Jul 1;132(13). doi: 10.1172/JCI142548.
7
Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study.根据癌症类型分析心房颤动的风险：一项基于全国人口的研究。
JACC CardioOncol. 2021 Jun 15;3(2):221-232. doi: 10.1016/j.jaccao.2021.03.006. eCollection 2021 Jun.
8
Guidelines and definitions for research on epithelial-mesenchymal transition.上皮-间质转化研究的指南和定义。
Nat Rev Mol Cell Biol. 2020 Jun;21(6):341-352. doi: 10.1038/s41580-020-0237-9. Epub 2020 Apr 16.
9
Handling of Ventricular Fibrillation in the Emergency Setting.急诊环境下心室颤动的处理
Front Pharmacol. 2020 Jan 29;10:1640. doi: 10.3389/fphar.2019.01640. eCollection 2019.
10
Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes.从心室和心房人多能干细胞来源的心肌细胞生成环形工程心脏组织。
Nat Commun. 2020 Jan 7;11(1):75. doi: 10.1038/s41467-019-13868-x.
Zotero 插件